Tumor-associated macrophages (TAM) are exposed to multiple microenvironmental cues in tumors, which collaborate to endow these cells with protumoral activities. Hypoxia, caused by an imbalance in oxygen supply and demand because of a poorly organized vasculature, is often a prominent feature in solid tumors. However, to what extent tumor hypoxia regulates the TAM phenotype in vivo is unknown. Here, we show that the myeloid infiltrate in mouse lung carcinoma tumors encompasses two morphologically distinct CD11b(hi)F4/80(hi)Ly6C(lo) TAM subsets, designated as MHC-II(lo) and MHC-II(hi) TAM, both of which were derived from tumor-infiltrating Ly6C(hi) monocytes. MHC-II(lo) TAM express higher levels of prototypical M2 markers and reside in more hypoxic regions. Consequently, MHC-II(lo) TAM contain higher mRNA levels for hypoxia-regulated genes than their MHC-II(hi) counterparts. To assess the in vivo role of hypoxia on these TAM features, cancer cells were inoculated in prolyl hydroxylase ... 
Introduction
Tumors are often highly infiltrated with inflammatory cells, such as tumor-associated macrophages (TAM). TAM are characterized by plasticity and versatility and may contribute to tumor progression via several mechanisms, including induction of angiogenesis, remodeling of the extracellular matrix, stimulation of cancer cell proliferation and metastasis, and the inhibition of adaptive immunity (1, 2) .
These different functions are exhibited by distinct TAM subpopulations, residing in distinct tumor microenvironments (3, 4) . In this context, it has been observed in several tumor models that macrophages can infiltrate both oxygenized perivascular regions as well as hypoxic tumor areas (4-7). Importantly, strong tumor hypoxia and a high density of hypoxic TAM have been shown to correlate with a decreased survival rate (8) . Although hypoxia can influence monocyte migration and macrophage proliferation and polarization (9) (10) (11) (12) , the precise role of tumor hypoxia in intratumoral monocyte differentiation and in shaping the molecular and functional TAM phenotype remains largely unexplored.
In this study, we used prolyl hydroxylase domain 2 (PHD2)-haplodeficient mice to evaluate the impact of tumor hypoxia on M2-like MHC-II lo and M1-like MHC-II hi TAM subpopulations, which both differentiate from Ly6C hi monocytes but reside in strongly hypoxic and less hypoxic regions, respectively. The oxygen-sensing PHD2 protein targets hypoxiainducible transcription factors (HIF) for degradation. Hence, its haplodeficiency creates a "genetic" type of hypoxia, resulting in tumor vessel normalization and tumor oxygenation (13) . Using PHD2 þ/À tumors, we demonstrated that hypoxia does not govern TAM subset differentiation and polarization, but regulates hypoxia-sensitive genes and angiogenic activity specifically in MHC-II lo TAM. Moreover, the diminished hypoxic signature of MHC-II lo TAM is recapitulated in PHD2 þ/þ ! PHD2 þ/À bone marrow chimeras, illustrating that a betteroxygenized microenvironment drives this phenomenon.
Materials and Methods
More detailed materials and methods can be found in the supplementary material.
Mice, cell line, and tumor models Female C57BL/6 mice were from Janvier. PHD2 þ/À and Cx3cr1 gfp/þ mice were provided by Peter Carmeliet (VIBKULeuven) and Frank Tacke (Aachen University), respectively. Procedures followed the guidelines of the Belgian Council for Laboratory Animal Science.
Mice were injected subcutaneously with 3 Â10 6 , or orthotopically with 5 Â 10 5 , 3LL-R Lewis lung carcinoma cells.
Tumor preparation, flow cytometry, and cell sorting
Tumor single-cell suspensions from subcutaneous and orthotopic 3LL-R tumors and sorted TAM were prepared as described (4) . Commercial antibodies for cell surface stainings are listed in Supplementary Table S1 . To prevent aspecific binding, TAMs were preincubated with rat anti-mouse CD16/ CD32 (clone 2.4G2; BD Biosciences).
To purify TAM or tumor-associated dendritic cells (TADC), cells were sorted using a BD FACSAria II (BD Biosciences) from 6 to 8 pooled tumors. To purify splenic conventional dendritic cells (DC), spleens were flushed with 200 U/mL collagenase III (Worthington) and squashed. Subsequently, CD11c þ cells were enriched via MACS, using anti-CD11c microbeads (Miltenyi Biotec), after which CD11c þ MHC-
Ly6C
À DCs were sorted using a BD FACSAria II.
Normalized delta-median fluorescence intensity (DMFI) was calculated as: [(MFI iNOS staining) À (MFI isotype staining)]/ (MFI iNOS staining). FACS data were acquired using a BD FACSCanto II (BD Biosciences).
RNA extraction, cDNA preparation, and quantitative real-time PCR These experiments were performed as described (4) . RNA was extracted using TRIzol (Invitrogen) and was reversetranscribed with oligo(dT) and SuperScript II RT (Invitrogen). Quantitative real-time PCR (qRT-PCR) was performed in an iCycler, with iQ SYBR Green Supermix (Bio-Rad). Primer sequences are listed in Supplementary Table S2 . PCR cycles consisted of 1 0 94 C, 45 00 55 C, 1 0 72 C. Gene expression was normalized using ribosomal protein S12 (Mrps12) as a housekeeping gene.
Measurement of arginase activity, NO, and interleukin-10 production
The arginase activity in the lysate of 5 Â 10 5 sorted TAM or TADC was measured as described (4) and NO 2 À was quantified by a Griess reaction (4) . Interleukin (IL)-10 concentrations were measured by Bio-Plex (Bio-Rad), according to the supplier's protocols.
Statistics
Significance was determined by the Student t test, using GraphPad Prism 4.0 software.
Results
Lung carcinomas are highly infiltrated with a heterogeneous myeloid cell compartment
To study the impact of hypoxia on tumor-associated macrophages, we investigated established subcutaneous 3LL-R tumors with an average tumor volume of 869 AE 75 mm 3 . These tumors possessed hypoxic areas, as demonstrated by pimonidazole staining (Fig. 1A) 6 ). All macrophage subsets showed a high expression of F4/80 and a typical macrophage scatter profile, whereas the TADC expressed higher levels of MHC-II, CD11c, costimulatory, and antigen-presenting molecules, but lower F4/80, CD64, and MerTK ( Fig. 1C and Supplementary Fig. S1A ), in combination with a characteristic DC morphology (Fig. 1B) . In a mixed leukocyte reaction, both TAM subsets were poor stimulators of naive CD4
þ and CD8 þ T cells compared with TADC, which are equally potent antigen-presenting cells as splenic conventional DC (Fig. Supplementary S1B and S1C). Moreover, at higher cell densities both TAM subsets suppress T-cell proliferation (Supplementary Fig. S1B and S1C). MHC-II lo and MHC-II hi TAM were morphologically distinct ( Supplementary Fig. S2B ). Notably, the proportion of distinct lung monocyte and macrophage populations was largely comparable between peritumoral normal lung tissue and naive lungs ( Supplementary Fig. S2C ).
MHC-II
lo and MHC-II hi TAM are derived from the same monocyte precursor but reside in differentially oxygenized tumor regions TAM subsets could be different because they are derived from distinct monocyte precursors or because they are subject to distinct microenvironments. Ly6C lo CX 3 CR1
hi monocytes are nearly undetectable at the tumor site (data not shown). Moreover, selective labeling of Ly6C hi or Ly6C lo monocytes in the circulation and subsequent tracing of labeled monocyte progeny in the tumor illustrated that exclusively Ly6C hi monocytes give rise to both TAM populations ( Fig. 2A) 2.2% ± 0.9% MHC-II lo TAM in this fraction. In conclusion, MHC-II lo TAM rather associate with hypoxic regions, whereas MHC-II hi TAM reside in less hypoxic areas.
Hypoxia does not define TAM differentiation and polarization, but specifically fine-tunes the molecular and functional profile of the MHC-II lo TAM subset To address whether hypoxia is the driving force behind TAM subset differentiation, 3LL-R tumors were inoculated in PHD2 þ/À mice. PHD2-haplodeficiency was shown before to foster vessel maturation and enhanced tumor oxygenation in several mouse tumor models without affecting primary tumor growth (13) . Accordingly, overall oxygen pressure was significantly increased and the hypoxic HP-1 þ area significantly reduced in PHD2 þ/À 3LL-R tumors ( Fig. 3A and B) . Tumor perfusion ( Supplementary Fig. S4B-S4D ) and vessel coverage ( Supplementary Fig. S4E -S4G) were also significantly higher in PHD2 þ/À tumors, whereas vessel density remained unchanged ( Supplementary Fig. S4A ), indicating that these vessels were more mature, tight, and stable. However, nearly no differences were observed at the level of myeloid cell infiltration, the relative abundance of MHC-II lo and MHC-II hi TAM, or the expression of prototypical M2 markers in these cells (Fig. 3C and D). Hence, hypoxia is not the main driver of TAM subset differentiation and polarization inside tumors.
We then assessed whether hypoxia contributes to a finetuning of the TAM phenotype. Corroborating their association with hypoxic regions, many of the hypoxia-dependent genes [Vegfa, Angpt2, Flt1 (VEGFR1), Kdr (VEGFR2), Egf, Slc2a1 (Glut1), Slc2a3 (Glut3), Ldha, Plau (uPA), Igf1, Serpine1 (PAI-1), Nos2 (iNOS), and Cxcl1 (KC)] were significantly upregulated in MHC-II lo TAM compared with MHC-II hi TAM in control tumors (Fig. 4A) . Interestingly, genes regulating angiogenesis, metabolism, or cancer cell invasiveness such as Vegfa, Slc2a1, Slc2a3, Serpine1, Plau, Nos2, and Cxcl1 were significantly downregulated in MHC-II lo TAM from PHD2 þ/À tumors compared with MHC-II lo TAM of control tumors. In contrast, the expression level of these hypoxia-regulated genes was less altered in MHC-II hi TAM of both genotypes. Hence, hypoxia regulates the expression of a subset of genes mainly in the MHC-II lo TAM population. For VEGF-A, GLUT-3, GLUT-1, and iNOS, these findings could be recapitulated at the protein level (Supplementary Fig. S5A and S5B) . In agreement, the in vivo angiogenic activity of MHC-II lo TAM from PHD2 þ/À tumors is significantly reduced as compared with their WT counterparts whereas this is not the case for MHC-II hi TAM (Fig. 4B) . A potential caveat for the interpretation of the results in PHD2 þ/À mice is the fact that also the macrophages in these mice are PHD2-haplodeficient, and hence experience a "genetic type" of hypoxia with a potential skewing of their activation state (14) . Therefore, we inoculated 3LL
hypoxic areas were smaller in the former (Fig. 4C) , illustrating that PHD2-haplodeficiency in nonhematopoietic cells is sufficient to increase oxygenation. In line with the data in PHD2 þ/À mice, many hypoxia-regulated genes were significantly down- (Fig. 4D) . These data corroborate the conclusion that environmental hypoxia mainly affects the MHC-II lo TAM phenotype.
Discussion
TAM reside in a complex microenvironment, so their molecular and functional profile is under the influence of multiple factors. In vivo evidence exists for the role of immune cell-and cancer cell-derived factors (e.g., cytokines such as IL-4 and IL-10, immunoglobulins, prostaglandin E 2 , exosomes) in shaping the protumoral functions of TAM during tumor progression (15, 16) . However, the impact of tumor hypoxia (0.1-3% O 2 ) is less clear in this respect, despite the known association of macrophages with hypoxic regions (4-7) .
Indeed, our data demonstrate the existence of at least 2 main TAM subsets, discriminated mainly by the differential MHC-II expression level, in subcutaneous and orthotopic lung carcinomas. Hereby the MHC-II lo subpopulation resides in more hypoxic regions as illustrated by intracellular FACS staining and immunohistochemistry upon pimonidazole treatment of the tumors. Earlier findings also pointed to the coexistence of TAM within hypoxic and less hypoxic regions in models of mouse mammary (4, 5) and human prostate carcinoma (6) . The molecular mechanisms responsible for the guidance of TAM toward hypoxic areas are not entirely clear, but it has been shown that the angiopoietin-2/Tie2 interaction regulates the vascular proximity of MMR þ
Tie2
þ macrophages (17) . Importantly, both TAM subsets derive from a common Ly6C hi monocyte precursor that continuously seeds the tumor, suggesting that distinct intratumoral cues drive the differentiating monocytes either to an MHC-II lo or MHC-II hi phenotype. One of the outstanding questions was whether hypoxia itself is the driving force behind this dichotomous monocyte differentiation. In addition, hypoxic MHC-II lo TAM express higher levels of prototype M2 markers such as MMR, IL-4Ra, and arginase, and it was unclear whether this activation state is regulated by oxygen deprivation.
We used PHD2-haplodeficient mice as a tool to directly alter oxygen availability in the tumor. Mazzone and colleagues (13) had demonstrated that the tumor vessels in these mice are more mature, increasing oxygen transport to the tumor, and that an endothelial cell-restricted PHD2-haplodeficiency is sufficient to drive this phenomenon. In agreement with these findings, oxygen pressure increases and the hypoxic area diminishes in 3LL-R tumors grown in PHD2 þ/À mice, as well
It is important to note that this approach more directly assesses the overall impact of hypoxia on tumor macrophages, in contrast to studies where macrophages were engineered to lack only HIF-1a or HIF-2a (18, 19) . Moreover, HIFs also act on gene transcription in a hypoxia-independent fashion, whereby HIF-1a is induced by Th1 cytokines in pro-inflammatory M1 macrophages and 
PHD2
þ/À bone marrow chimeras. Expression levels were first normalized based on the S12 gene and calculated as the fold induction compared with the expression in sorted peritoneal macrophages. Bars represent the up-or downregulation of the expression of the indicated genes, compared with the corresponding TAM subset in control bone marrow chimeras. All experiments, n ! 3. Ã , P < 0.05; ÃÃ , P < 0.01; ÃÃÃ , P < 0.001.
HIF-2a by Th2 cytokines in M2 macrophages (20) . Our findings in PHD2-haplodeficient mice demonstrate that the tumor oxygenation state does not significantly alter the attraction of monocytes to the tumor nor the efficiency of monocyte differentiation into M2-like MHC-II lo or M1-like MHC-II hi TAM. Reduced hypoxia also does not seem to affect the expression of such M2-markers as MMR, IL-4Ra, and arginase in MHC-II lo TAM, but rather downregulates their expression of typical hypoxia-responsive genes involved in glycolysis (Slc2a1, Slc2a3, Ldha), angiogenesis (Vegfa, Angpt1, Angpt2, Kdr, Nos2, Cxcl1), and metastasis (Egf, uPA, uPAR, Igf1, Serpine1). These results were phenocopied in PHD2 þ/þ ! PHD2 þ/À chimeras, illustrating that the PHD2-haplodeficiency in macrophages does not majorly account for the observed changes in gene expression. Together, our data suggest a model whereby tumor-infiltrating Ly6C hi monocytes either become MHC-II lo M2-like TAM or MHC-II hi M1-like TAM under the influence of microenvironmental stimuli other than hypoxia. Once formed, MHC-II lo TAM are preferentially attracted to hypoxic regions where they upregulate hypoxia-regulated genes and their angiogenic capacity. By contrast, MHC-II hi TAM remain largely unaffected by hypoxia.
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